Skip to main content
. 2013 Feb 21;42(4):972–981. doi: 10.1183/09031936.00165712

Table 5– Most common on-treatment adverse events (≥3% incidence in any treatment group).

Placebo Salmeterol GSK961081
Twice daily Once daily
100 μg 200 μg 400 μg 100 μg 400 μg 800 μg
Subjects 81 47 52 50 54 50 50 52
Any adverse event 20 (25) 8 (17) 12 (23) 12 (24) 16 (30) 16 (32) 15 (30) 13 (25)
Headache 5 (6) 2 (4) 2 (4) 5 (9) 5 (10) 5 (10) 2 (4)
Cough 2 (2) 2 (4) 4 (8) 1 (2) 5 (10) 5 (10) 4 (8)
Dysgeusia 2 (4) 3 (6) 3 (6) 2 (4) 1 (2)
Nasopharyngitis 3 (4) 1 (2) 3 (6) 3 (6) 1 (2)
Back pain 2 (2) 1 (2) 2 (4)
Dysphonia 2 (2) 1 (2) 2 (4)
Muscle spasms 1 (2) 1 (2) 2 (4) 1 (2)
Nausea 2 (2) 1 (2) 2 (4)
Myalgia 1 (1) 1 (2) 2 (4)
Palpitations 1 (2) 2 (4)

Data are presented as n or n (%).